DOCU vs TERN · P/E 15, rev $2.98B vs $6.12B cap
DocuSign Inc (DOCU) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the DOCU and TERN stock pages for the full models.
Not investment advice.